Don Sawyer

Don Sawyer joined Regeneron in 2024 and serves as senior vice president, global market access. Most recently, Mr. Sawyer was senior vice president, market access, for Stemline Therapeutics, part of the Menarini Group. Mr. Sawyer has also led Market Access functions at AstraZeneca, Celgene and Bayer, along with startup companies Ironwood Pharmaceuticals and Acceleron Pharma. He received a J.D. from Widener University’s Delaware Law School and a B.A. from the University of Delaware.